The present invention relates to a vaccine effective against the Zika virus (ZIKV) of inactivated Zika virus plaque-forming units (PFU) associated with outer membrane vesicles of Neisseria meningitidus (OMV) and of nanoparticles of vaccine adjuvant.
展开▼